Maravai Lifesciences Holdings, Inc. (MRVI)
3.93
+0.08
(+2.08%)
USD |
NASDAQ |
Jan 09, 16:00
3.94
+0.01
(+0.25%)
After-Hours: 20:00
Maravai Lifesciences Holdings Profit Margin (Quarterly): -108.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Rockwell Medical, Inc. | -11.01% |
| AdaptHealth Corp. | 2.89% |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.88% |
| Return on Assets | -21.46% |
| Return on Invested Capital | -23.17% |
| Gross Profit Margin (Quarterly) | 12.14% |
| Operating Margin (Quarterly) | -21.15% |
| Return on Net Operating Assets | -35.89% |